home / stock / cmpi / cmpi news


CMPI News and Press, Checkmate Pharmaceuticals Inc.

Stock Information

Company Name: Checkmate Pharmaceuticals Inc.
Stock Symbol: CMPI
Market: NASDAQ
Website: checkmatepharma.com

Menu

CMPI CMPI Quote CMPI Short CMPI News CMPI Articles CMPI Message Board
Get CMPI Alerts

News, Short Squeeze, Breakout and More Instantly...

CMPI - Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment

Ad-hoc announcement pursuant to Article 53 of the SIX listing rules •  $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” ...

CMPI - University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat c...

CMPI - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SWCH, TREC, CMPI, FSI

NEW YORK, NY / ACCESSWIRE / May 13, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Switch, Inc. (NYSE:SWCH)'s sale to ...

CMPI - Checkmate Pharmaceuticals GAAP EPS of -$0.73 beats by $0.02

Checkmate Pharmaceuticals press release (NASDAQ:CMPI): Q1 GAAP EPS of -$0.73 beats by $0.02. “We remain focused on the execution of the clinical program for vidutolimod and are delighted with the opportunity to become part of Regeneron, who will help to accelerate the development of vi...

CMPI - Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update

CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today an...

CMPI - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNR, CMPI, SBOW, VWTR

NEW YORK, NY / ACCESSWIRE / May 5, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cornerstone Building Brands, Inc. (NYS...

CMPI - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, PSB, CMPI, CLBS

NEW YORK, NY / ACCESSWIRE / April 29, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Campus Communities, Inc. (...

CMPI - Merger Arbitrage Mondays - Blackstone Acquires American Campus Communities

The largest deal announced last week was the acquisition of American Campus Communities (ACC) by Blackstone (BX) for nearly $13 billion. The deal represents a premium of 30% over the closing stock price of February 16, 2022, the date immediately prior to the company disclosing receipt...

CMPI - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, CMPI, CNR, EXTN

NEW YORK, NY / ACCESSWIRE / April 21, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Campus Communities, Inc. (...

CMPI - Adaptimmune in two-day rally thanks to Regeneron/Checkmate deal; shares up 15%

Adaptimmune Therapeutics (NASDAQ:ADAP) is up 15% in trading on Wednesday and up ~21% since Monday's close as a likely beneficiary of Regeneron Pharmaceuticals' (REGN) $250M acquisition of Checkmate Pharmaceuticals (CMPI) announced Tuesday. Like Checkmate (CMPI), ...

Next 10